Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02952742Phase 2Withdrawn
Phase 2, randomised, double-blind trial (2 arms), sponsored by City of Hope Chicago. Primary endpoint: Frequency of hot flashes. Planned start Nov 2016; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02952742.